Lanean...
CAR T Cells: New Approaches to Improve Their Efficacy and Reduce Toxicity
The durable remission of B-cell leukemia and lymphoma following chimeric antigen receptor T (CART) cell therapy has brought this new form of adoptive immunotherapy to center stage with the expectation that CART cell therapy may provide similar efficacy in other hematological and solid cancers. Herei...
Gorde:
| Argitaratua izan da: | Cancer J |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4656124/ https://ncbi.nlm.nih.gov/pubmed/26588679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000155 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|